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Background
Hypertension, the leading risk factor for cardiovascular
mortality has been associated with alterations in endothe-
lium- and smooth muscle-dependent vascular relaxation.
The NO/cGMP signaling cascade is one of the major path-
ways that mediate vascular relaxation. In this pathway, the
NO receptor guanylyl cyclase (NO-GC) holds a key posi-
tion by converting the NO signal into cGMP increases.
Two isoforms of the heterodimeric NO receptor GC exist;
both isoforms share an identical β subunit but differ in
their respective α subunit (α1 or α2) and are referred to as
NO-GC1 (so far α1β1heterodimer) and NO-GC2 (so far
α2β1heterodimer), respectively. Knockout (KO) mice defi-
cient in either one of the NO-GCs, NO-GC1 or NO-GC2,
revealed that both NO-GCs are capable to mediate vascu-
lar relaxation. The NO-GC1 appears to be the major iso-
form, particularly in the aorta, where NO-GC1 represents
approximately 90% of total NO-GC content. Deletion of
the NO-GC1 resulted in reduced endothelium-dependent
relaxation and reduced vasodilatory response to exoge-
nous NO, which is mediated by the NO receptor GC2 in
NO-GC1-deficient mice. Despite the low NO-GC2 con-
tent, NO-GC1 KO mice exhibit only a minute blood pres-
sure increase.
Results
In the present study, we used the Goldblatt model of ren-
ovascular hypertension (2 kidney 1 clip [2K1C] opera-
tion) to induce hypertension in the NO-GC1 KO mice
and investigated the impact of renovascular hypertension
in aorta and renal vasculature of 2K1C-operated NO-GC1-
deficient mice. Much to our surprise, blood pressure
increases induced by the 2K1C operation did not differ
between NO-GC1 KO and WT mice. Moreover, unlike as
in WT mice, the 2K1C operation did not cause a reduction
of endothelium-dependent relaxation in the NO-GC1-
deficient mice. The reduced endothelium-dependent
relaxation observed in WT vessels was paralleled by a
reduced response to exogenous NO indicating an altera-
tion of smooth muscle relaxation induced by the 2K1C
operation. An increase of phosphorylated PDE5 indicates
activation of PDE5 as the underlying mechanism for the
attenuated vasodilatory response.
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